UCLA Journal of Radiation Oncology January 1, 2022 - Flipbook - Page 38
UCLA RADIATION ONCOLOGY JOURNAL
of overall grade ≥2 radiation morbidity in
this same group was 12.9%. Major wound
complications were observed in 22 out of 91
(24.2%) evaluable patients.
Overall, these results show excellent local
control rates with acceptable toxicities and
wound complications.
AUTHORS
The first author and presenter is Ricky R.
Savjani, a resident physician in the Radiation
Oncology Residency Program at UCLA and a
researcher at UCLA Jonsson Comprehensive
Cancer Center. The Principal Investigator
for the clinical trial is A. Kalbasi. Additional
UCLA Jonsson Comprehensive Cancer
Center co-authors are Scott D. Nelson, Sarah
M. Dry, Jackie Hernandez, Natalie Chong,
Bartosz Chmielowski, Arun S. Singh, Joseph
G. Crompton, Brooke Crawford, Susan V.
Bukata, Brian Kadera, Nicholas M. Bernthal,
Joanne B. Weidhaas, Michael L. Steinberg,
Fritz C. Eilber, Anusha Kalbasi. Co-author
Mitchell Kamrava is from Cedars-Sinai
Medical Center.
JOURNAL/MEETING
Study results were presented at ASTRO 2021,
the Annual Meeting of the American Society
for Radiation Oncology, held in Chicago from
October 24-27, 2021. ☐
38